UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia

Leukemia, 2011-10, Vol.25 (10), p.1543-1547

2011

Link zum Volltext

Verfügbarkeit prüfen

P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON‐BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS

HemaSphere, 2022-06, Vol.6 (Suppl), p.835-836

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.278-283

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Study of the P-Glycoprotein Modulator PSC 833 in Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1589-1599

2001

Link zum Volltext

Verfügbarkeit prüfen

The Bruton's tyrosine kinase inhibitor ibrutinib in combination with carfilzomib in patients with relapsed or relapsed and refractory multiple myeloma: initial results from a multicenter phase 1/2b study

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e275-e276

2015

Link zum Volltext

Verfügbarkeit prüfen

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

The New England journal of medicine, 2023-09, Vol.389 (11), p.1009-1022

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3244-3254

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma

Leukemia & lymphoma, 2018-11, Vol.59 (11), p.2588-2594

2018

Link zum Volltext

Verfügbarkeit prüfen

Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (7), p.675-676

2008

Link zum Volltext

Verfügbarkeit prüfen

Disseminated toxoplasmosis in marrow recipients : a report of three cases and a review of the literature

Bone marrow transplantation (Basingstoke), 1997-04, Vol.19 (7), p.685-689

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Leukemia, 2017-12

2017

Link zum Volltext

Verfügbarkeit prüfen

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

Blood, 2001-12, Vol.98 (12), p.3212-3220

2001

Link zum Volltext

Verfügbarkeit prüfen

Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4377-4385

2000

Link zum Volltext

Verfügbarkeit prüfen

Low Infectious Morbidity after Intensive Chemotherapy and Autologous Peripheral Blood Progenitor Cell Transplantation in the Outpatient Setting for Women with Breast Cancer

Clinical infectious diseases, 2001-02, Vol.32 (4), p.546-551

2001

Link zum Volltext

Verfügbarkeit prüfen

Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature

Leukemia, 2000-06, Vol.14 (6), p.1044-1051

2000

Link zum Volltext

Verfügbarkeit prüfen

PS1390 PRELIMINARY DATA: PHASE 1B STUDY OF FEASIBILITY/SAFETY OF ISATUXIMAB SHORT DURATION FIXED VOLUME INFUSION IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

HemaSphere, 2019-06, Vol.3 (S1), p.637-638

2019

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Cytosine Arabinoside Therapy for Refractory Leukemia

Blood, 1983-08, Vol.62 (2), p.361-369

1983

Link zum Volltext

Verfügbarkeit prüfen

Successful allogeneic bone marrow transplantation in selected patients over 50 years of age : A single institution's experience

Bone marrow transplantation (Basingstoke), 1998-05, Vol.21 (10), p.1043-1047

1998

Link zum Volltext

Verfügbarkeit prüfen

Unrelated donor stem cell transplant: donor selection and search process

Pediatric transplantation, 2003-01, Vol.7 (s3), p.59-64

Karanes, Chatchada

2003

Link zum Volltext

Verfügbarkeit prüfen

Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations

Radiology, 1990-10, Vol.177 (1), p.209

1990

Link zum Volltext

Verfügbarkeit prüfen

A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients

Bone marrow transplantation (Basingstoke), 2000-02, Vol.25 (3), p.283-291

2000

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow and Peripheral Blood Hematopoietic Stem Cell Transplantation: Focus on Autografting

Clinical chemistry (Baltimore, Md.), 2000-08, Vol.46 (8), p.1239-1251

2000

Link zum Volltext

Verfügbarkeit prüfen

A phase I MMRC clinical trial testing the combination of bortezomib and tipifarnib in relapsed/refractory multiple myeloma

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8597-8597

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(121)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(123)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(72)
Life Sciences & Biomedicine
(71)
Science & Technology
(71)
Biological And Medical Sciences
(55)
Medical Sciences
(54)
Female
(50)
Middle Aged
(50)
Adult
(49)
Male
(47)
Oncology
(44)
Hematology
(38)
Aged
(26)
Pharmacology. Drug Treatments
(25)
Adolescent
(24)
Bone Marrow Transplantation
(24)
Transplantation
(21)
Chemotherapy
(20)
Immunology
(20)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(18)
Antineoplastic Agents
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Biology Of Blood And Marrow Transplantation
(27)
Bone Marrow Transplantation
(20)
Blood
(10)
Journal Of Clinical Oncology
(5)
Leukemia
(5)
Cancer
(4)
Leukemia Research
(4)
American Journal Of Clinical Oncology
(3)
Leukemia & Lymphoma
(3)
Hemasphere
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia

P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON‐BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS

A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant

Phase I/II Study of the P-Glycoprotein Modulator PSC 833 in Patients With Acute Myeloid Leukemia

The Bruton's tyrosine kinase inhibitor ibrutinib in combination with carfilzomib in patients with relapsed or relapsed and refractory multiple myeloma: initial results from a multicenter phase 1/2b study

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma

Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor

Disseminated toxoplasmosis in marrow recipients : a report of three cases and a review of the literature

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis

Low Infectious Morbidity after Intensive Chemotherapy and Autologous Peripheral Blood Progenitor Cell Transplantation in the Outpatient Setting for Women with Breast Cancer

Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature

PS1390 PRELIMINARY DATA: PHASE 1B STUDY OF FEASIBILITY/SAFETY OF ISATUXIMAB SHORT DURATION FIXED VOLUME INFUSION IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

High-Dose Cytosine Arabinoside Therapy for Refractory Leukemia

Successful allogeneic bone marrow transplantation in selected patients over 50 years of age : A single institution's experience

Unrelated donor stem cell transplant: donor selection and search process

Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations

A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients

Bone Marrow and Peripheral Blood Hematopoietic Stem Cell Transplantation: Focus on Autografting

A phase I MMRC clinical trial testing the combination of bortezomib and tipifarnib in relapsed/refractory multiple myeloma

Suchergebnisse filtern